FY2017 EPS Estimates for Aetna Inc. Lifted by Oppenheimer Holdings (AET)

Aetna Inc. (NYSE:AET) – Equities research analysts at Oppenheimer Holdings lifted their FY2017 EPS estimates for shares of Aetna in a report issued on Tuesday. Oppenheimer Holdings analyst M. Wiederhorn now expects that the company will post earnings per share of $9.83 for the year, up from their prior forecast of $9.55. Oppenheimer Holdings also issued estimates for Aetna’s Q4 2017 earnings at $1.21 EPS, Q2 2018 earnings at $2.82 EPS and FY2018 earnings at $10.09 EPS.

Aetna (NYSE:AET) last released its quarterly earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.06 by $0.39. Aetna had a return on equity of 21.84% and a net margin of 2.93%. The firm had revenue of $14.99 billion for the quarter, compared to analyst estimates of $15.12 billion. During the same quarter last year, the company posted $2.07 earnings per share. The business’s revenue was down 5.0% on a year-over-year basis. ILLEGAL ACTIVITY WARNING: “FY2017 EPS Estimates for Aetna Inc. Lifted by Oppenheimer Holdings (AET)” was first posted by Community Financial News and is the property of of Community Financial News. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this piece of content can be read at https://www.com-unik.info/2017/11/03/fy2017-eps-estimates-for-aetna-inc-lifted-by-oppenheimer-holdings-aet.html.

Other equities analysts also recently issued reports about the stock. BidaskClub downgraded shares of Aetna from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 19th. Argus reissued a “buy” rating and set a $185.00 price target (up from $165.00) on shares of Aetna in a report on Tuesday, September 12th. Zacks Investment Research raised shares of Aetna from a “hold” rating to a “buy” rating and set a $174.00 price target for the company in a report on Thursday, October 12th. Citigroup Inc. lifted their price target on shares of Aetna from $183.00 to $197.00 and gave the company a “buy” rating in a report on Thursday. Finally, Jefferies Group LLC lifted their price target on shares of Aetna from $163.00 to $165.00 and gave the company a “hold” rating in a report on Friday, October 13th. Eleven equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. Aetna has a consensus rating of “Buy” and an average target price of $166.09.

The firm also recently declared a quarterly dividend, which was paid on Friday, October 27th. Stockholders of record on Thursday, October 12th were given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.16%. The ex-dividend date was Wednesday, October 11th. Aetna’s dividend payout ratio is 37.04%.

In related news, President Karen S. Lynch sold 15,271 shares of the business’s stock in a transaction that occurred on Monday, September 18th. The shares were sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the completion of the transaction, the president now owns 64,261 shares in the company, valued at $10,404,498.51. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Margaret M. Mccarthy sold 10,288 shares of the business’s stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the transaction, the executive vice president now owns 33,563 shares of the company’s stock, valued at approximately $5,465,734.55. The disclosure for this sale can be found here. 0.90% of the stock is owned by insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Guardian Life Insurance Co. of America grew its holdings in Aetna by 0.7% during the first quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock valued at $173,000 after purchasing an additional 9 shares during the period. Financial Architects Inc grew its holdings in Aetna by 1.8% during the second quarter. Financial Architects Inc now owns 1,746 shares of the company’s stock valued at $265,000 after purchasing an additional 31 shares during the period. Wedbush Securities Inc. grew its holdings in Aetna by 1.4% during the second quarter. Wedbush Securities Inc. now owns 3,779 shares of the company’s stock valued at $574,000 after purchasing an additional 52 shares during the period. Calamos Wealth Management LLC grew its holdings in Aetna by 0.7% during the second quarter. Calamos Wealth Management LLC now owns 8,919 shares of the company’s stock valued at $1,354,000 after purchasing an additional 65 shares during the period. Finally, HM Payson & Co. grew its holdings in Aetna by 0.5% during the first quarter. HM Payson & Co. now owns 12,861 shares of the company’s stock valued at $1,641,000 after purchasing an additional 69 shares during the period. Hedge funds and other institutional investors own 89.45% of the company’s stock.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Earnings History and Estimates for Aetna (NYSE:AET)

What are top analysts saying about Aetna Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Aetna Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit